Dermatologica Sinica

Papers
(The TQCC of Dermatologica Sinica is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Ten essential steps for performing a systematic review: A quick tutorial20
Risk of chronic kidney disease and end-stage renal disease in patients with psoriasis: A systematic review and meta-analysis of cohort studies11
Using Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to rate the certainty of evidence of study outcomes from systematic reviews: A quick tutorial10
Increased risk of alopecia areata among patients with endometriosis: A longitudinal study in Taiwan9
Perspective approaches on melanogenesis inhibition9
Taiwan dermatological association recommendations for coronavirus disease of 2019 vaccination in patients treated with immunotherapeutics8
Long-term effectiveness and safety of ixekizumab in the treatment of 14 patients with a history of chronic erythrodermic psoriasis who failed prior secukinumab: A bicentric retrospective study7
Recommendations on use of systemic treatments for immune-mediated dermatologic disorders in patients with confirmed COVID-19 infection: A rapid review6
Psoriasis flare following ChAdOx1-S/nCoV-19 vaccination in patients with psoriasis under biologic treatment6
Alcohol consumption, aldehyde dehydrogenase 2 gene rs671 polymorphism, and psoriasis in Taiwan6
Coronavirus disease 2019 in dermatology practice: Perspective of three levels of prevention on public health5
Prenatal infection predisposes offspring to enhanced susceptibility to imiquimod-mediated psoriasiform dermatitis in mice5
Refractory bullous pemphigoid with prurigo nodularis successfully treated with dupilumab monotherapy5
The influence of gender and smoking on hidradenitis suppurativa: A retrospective study of 161 patients in Taiwan5
Drug survival of biologic agents in patients with psoriatic arthritis from a medical center in southern Taiwan5
The cutaneous manifestations related to COVID-19 infection and vaccination: current aspects and future prospects5
Cutaneous manifestations of coronavirus disease in Turkey: A prospective study5
Plasmacytoid dendritic cells diminution in peripheral blood is prevalent in drug reaction with eosinophilia and systemic symptoms and may precede human herpesvirus 6 reactivation4
Venous thromboembolism in a case with pemphigus vulgaris after infusion of rituximab plus systemic glucocorticoids and azathioprine: A possible adverse effect of rituximab?4
Statins did not reduce the mortality risk in patients with bullous pemphigoid: A population-based cohort study4
New-onset bullous pemphigoid triggered by AstraZeneca COVID-19 vaccine4
Autoinflammatory keratinization diseases: The concept, diseases involved, and pathogeneses4
Diagnostic value of microRNA-106a-5p in patients with psoriasis and its regulatory role in inflammatory responses4
Correlation of clinical diagnosis of dactylitis by the dermatologist and ultrasonographic diagnosis by the rheumatologist in patients with psoriasis arthritis: Experience of a single clinic4
An elderly female with pemphigus foliaceus possibly induced by losartan/hydrochlorothiazide3
Skin microbiome in acne vulgaris, skin aging, and rosacea: An evidence-based review3
Lymphomatoid papulosis with DUSP22-IRF4 rearrangement on 6p25-3: A case report3
Dermatological management in special population affected by psoriasis: A case report of an amputated transgender with psoriasis treated with apremilast3
The seroconversion rate of QuantiFERON-TB gold in-tube test in psoriatic patients receiving anti-interleukin-23 monoclonal antibodies3
Hair loss and COVID-193
Comparison of 1550-nm nonablative fractional laser versus 755-nm picosecond laser with diffractive lens array for atrophic facial acne scars in asian skin: A prospective randomized split-face clinical3
AZ arm: Delayed cutaneous reaction to ChAdOx1 nCoV-19 (AZD1222) vaccine3
Radiation-induced bullous pemphigoid in a patient with Kaposi's sarcoma3
Dyshidrotic bullous pemphigoid developing after Moderna mRNA-1273 vaccination3
Levels of evidence and study designs: A brief introduction to dermato-epidemiologic research methodology2
Atrophying pityriasis versicolor: A rare variant with review of literature2
Tocilizumab-induced psoriasis in a patient with rheumatoid arthritis: A case report and literature review2
Erythrodermic bullous pemphigoid2
Recurrent angiolymphoid hyperplasia with eosinophilia with CCR4 expression2
Anti-inflammatory effect of hydrogen sulfide donor sodium-sulfide in an experimental mouse model of contact hypersensitivity2
Parvovirus B19 infection simulating a vesicular exanthem associated with COVID-192
Genetic associations of human leukocyte antigen alleles in cutaneous delayed drug hypersensitivity reactions: An updated review2
Pemphigus scoring systems and their validation studies – A review of the literature2
Radiation recall dermatitis triggered by the AstraZeneca COVID-19 vaccine: A case report and literature review2
Erythrodermic psoriasis following ChAdOx1 nCOV-19 vaccination: A case report2
Histoid leprosy complicated with Charcot neuroarthropathy: A case report2
Apremilast for lithium-associated psoriasis2
Hints from the skin beneath: Vitiligo in Vogt–Koyanagi–Harada disease2
Bullous vasculitis following COVID-19 vaccination2
Two cases with dermatomyositis-like skin rash and myopathy following COVID-19 vaccination2
A case of papuloerythroderma of Ofuji possibly associated with a combination drug of losartan potassium/hydrochlorothiazide2
Aiming at a bright future2
Reliability and validity of the Chinese version of the vitiligo specific quality of life instrument (VitiQoL)2
Mortality and cause of death in patients with dermatologic diseases: An 11-year record-based observational study2
Use of brodalumab for the treatment of pyoderma gangrenosum: A case report2
Aortic stiffness in hidradenitis suppurativa: A case-control study2
0.044783115386963